![Tern plc](https://directorstalk.net/wp-content/uploads/2023/03/Tern-plc-300x300.jpg)
AI-powered data intelligence transforming healthcare marketing
Experience how Talking Medicines revolutionises healthcare marketing with AI and data intelligence. Learn how they are reshaping the industry with innovative solutions.
Experience how Talking Medicines revolutionises healthcare marketing with AI and data intelligence. Learn how they are reshaping the industry with innovative solutions.
Device Authority strengthens its commitment to Managed Security Service Providers in North America, offering automated solutions to enhance IoT security.
In 2025, AI is revolutionizing Healthcare Marketing, enhancing productivity, patient engagement, and campaign results. Discover how AI is driving the future of the industry this year.
Unlock the power of AI in healthcare analytics with Drug-GPT from Talking Medicines. Transform vast data into actionable insights for smarter decisions.
Tern drives innovation in IoT and AI sectors through strategic investments and collaborations, showcasing its strong momentum in disruptive technologies.
Discover the crucial role of AI governance in the pharmaceutical industry, ensuring ethical innovation and patient trust in this insightful article.
Discover how FundamentalVR is leading the charge in revolutionizing healthcare education with its award-winning Surgery Training VR Technology.
The rise of IoT devices has brought unprecedented connectivity but also increased vulnerability to cyber attacks. Learn how to protect your devices effectively.
Understanding the preferences, trends, and experiences of both patients and healthcare professionals (HCPs) is key to developing effective healthcare marketing strategies. However, the challenge of managing unstructured data remains significant,
Tern Plc (LON:TERN), the investment company specialising in supporting high growth, early-stage, disruptive Internet of Things technology businesses, has announced that the Company will be hosting an online presentation and Q&A session at